A press release from the Medical Research Council-The Gambia at the London School of Hygiene and Tropical Medicine (MRCG at LSHTM) on Tuesday, June 24, 2025, stated that the World Health Organisation ...

Vaxcyte's new pneumococcal vaccine may only have phase 1/2 results behind it, but analysts are already predicting it could be a major competitor to rival shots from Pfizer and MSD.

Prior to COVID-19, pneumococcal vaccines were the largest vaccine market worldwide – estimated at around $8 billion – with Prevnar 13 capturing almost $6 billion of that last year from its use ...

A whopping 1.44 million children in India did not receive a single shot of any routine vaccination in 2023, a new global ...

SK bioscience expands pneumococcal vaccine facility amid global collaboration efforts SK bioscience held a completion ceremony on the 30th to celebrate the expansion of the pneumococcal vaccine ...

NHSGGC launches drop-in vaccination clinics for adults in July-August, offering personalised advice and access to shingles, ...

Biological E’s PCV14 – a 14-valent pneumococcal conjugate vaccine, having broad serotype coverage – was found to be ...

There’s no denying: this is a global health crisis. Between the U.S. cuts and other funding cuts, in total, aid in total has ...

India is among the countries with the highest number of zero-dose children, according to a Lancet report. The study revealed ...

Safe dividend-paying income stocks trading under $30 are passive income home runs. Stocks trading under the $30 level offer Boomers a larger share count when they buy. With the geopolitical ...